Treating Advanced Sarcoma: One Size Does Not Fit All
1 vistas
• 07/18/23
0
0
Empotrar
administrator
Suscriptores
Dr. Nikhil Khushalani, Section Chief of Soft Tissue and Melanoma & Director of the IL-2 Program, Department of Medicine, RPCI, gives an overview of the treatment strategies used in advanced soft tissue sarcoma, including a new drug, approved by the FDA in April 2012, called pazopanib.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios